Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Hernandez-Boluda JC, Pereira A, Alvarez-Larran A, Martin AA, Benzaquen A, Aguirre L, Mora E, Gonzalez P, Mora J, Dorado N, Sampol A, Garcia-Gutierrez V, Lopez-Godino O, Fox ML, Reguera JL, Perez-Encinas M, Pascual MJ, Xicoy B, Parody R, Gonzalez-Pinedo L, Espanol I, Avendano A, Correa JG, Vallejo C, Jurado M, Garcia-Cadenas I, Osorio S, Duran MA, Sanchez-Guijo F, Cervantes F, Pinana JL. Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model. Biol Blood Marrow Transplant. 2020 Dec;26(12):2237-2244. doi: 10.1016/j.bbmt.2020.07.022. Epub 2020 Jul 24. PubMed PMID: 32717433.
AÑO: 2020; IF: 5.742
32717433
Conteduca V, Wetterskog D, Scarpi E, Romanel A, Gurioli G, Jayaram A, Lolli C, Tandefelt DG, Schepisi G, Casadei C, Wingate A, Matteucci F, Paganelli G, Gonzalez-Billalabeitia E, Demichelis F, De Giorgi U, Attard G. Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer. Br J Cancer. 2020 Sep;123(6):982-987. doi: 10.1038/s41416-020-0969-5. Epub 2020 Jul 16. PubMed PMID: 32669676; PubMed Central PMCID: PMC7492429.
AÑO: 2020; IF: 7.64
32669676
Fuster JL, Molinos-Quintana A, Fuentes C, Fernandez JM, Velasco P, Pascual T, Rives S, Dapena JL, Sisinni L, Lopez-Godino O, Palomo P, Villa-Alcazar M, Bautista F, Gonzalez-Vicent M, Lopez-Duarte M, Garcia-Morin M, Ramos-Elbal E, Ramirez M; Leukemia Working Group of the Spanish Society of Pediatric Hematology, Oncology (SEHOP). Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP). Br J Haematol. 2020 Sep;190(5):764-771. doi: 10.1111/bjh.16647. Epub 2020 Apr 21. PubMed PMID: 32314348.
AÑO: 2020; IF: 6.998
32314348
Martinez C, Carpio C, Heras I, Rios-Herranz E, Buch J, Gutierrez A, Romero S, Zeberio I, Garcia-Garcia I, Rodriguez-Izquierdo A, Alonso R, Bargay J, Barrenetxea C, Domingo-Domenech E, de Haro ME, Palomera L, Garcia-Sanz R; Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO). Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain. Biol Blood Marrow Transplant. 2020 Aug;26(8):1534-1542. doi: 10.1016/j.bbmt.2020.02.003. Epub 2020 Feb 14. PubMed PMID: 32068094.
AÑO: 2020; IF: 5.742
32068094
de la Morena-Barrio ME, Sabater M, de la Morena-Barrio B, Ruhaak RL, Minano A, Padilla J, Toderici M, Roldan V, Gimeno JR, Vicente V, Corral J. ALG12-CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant. Mol Genet Genomic Med. 2020 Aug;8(8):e1304. doi: 10.1002/mgg3.1304. Epub 2020 Jun 12. PubMed PMID: 32530140; PubMed Central PMCID: PMC7434597.
AÑO: 2020; IF: 2.183
32530140
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL